Cognex Corp. (CGNX) Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 29, 2025. Cognex Corporation is a leading global provider of machine vision products and solutions used in manufacturing and distribution. The company operates as a single segment focused on machine vision technology, serving industries such as logistics, automotive, consumer electronics, and semiconductors.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenue | $249.1 million | $239.3 million | $465.1 million | $450.1 million |
| Gross Profit | $167.9 million | $166.6 million | $312.2 million | $308.5 million |
| Gross Margin | 67.4% | 69.6% | 67.1% | 68.5% |
| Operating Income | $43.4 million | $38.5 million | $69.5 million | $52.7 million |
| Net Income | $40.5 million | $36.2 million | $64.1 million | $48.2 million |
| Diluted EPS | $0.24 | $0.21 | $0.38 | $0.28 |
| Cash from Operations (YTD) | $83.1 million (vs. $41.4 million YTD 2024) | |||
| Cash & Investments | $552.6 million (as of June 29, 2025) | |||
| Debt | No long-term debt reported |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 4% in Q2 and 3% YTD compared to 2024. Growth was driven by strong performance in logistics and factory automation, partially offset by weakness in the automotive sector.
- Geographic Shifts: Americas revenue grew 8% (Q2) and 14% (YTD); Europe grew 17% (Q2) and 6% (YTD). Conversely, Greater China revenue declined 17% (Q2) and 15% (YTD), attributed to procurement shifts by consumer electronics customers from China to Europe and Other Asia.
- Margin Compression: Gross margin decreased from 70% to 67% in Q2, primarily due to less favorable industry mix and tariff impacts.
- Expense Management: Operating expenses decreased 3% in Q2 due to disciplined cost management, including reductions in R&D and SG&A headcount.
- Share Repurchases: The company repurchased 3.05 million shares for $102.2 million during the first six months of 2025. $164.0 million remains available under the current buyback program.
Outlook, Risks, and Unusual Items
- Tax Legislation Impact: The "One Big Beautiful Bill Act" (OBBBA) enacted on July 4, 2025, is expected to materially increase deferred tax liabilities and income tax expense in Q3 2025. However, it is projected to provide a cash tax benefit of $12 million to $15 million for the full year.
- Subsequent Event (Revenue Boost): In July 2025, Cognex entered a commercial partnership for medical lab automation. The company expects to recognize a one-time revenue benefit of $8 million to $14 million in Q3 2025 due to upfront license fee recognition.
- Dividends: A cash dividend of $0.08 per share was declared on July 30, 2025, payable August 28, 2025.
- Risks: Key risks include continued weakness in the automotive industry, geopolitical tensions affecting trade (specifically in China), supply chain constraints, and the impact of new tax legislation.
Investor Verification Checklist
- Q3 Tax Impact: Verify the specific magnitude of the deferred tax liability increase and expense recognition in the upcoming Q3 filing due to the OBBBA.
- Partnership Revenue: Confirm the timing and amount of the $8–14 million revenue recognition from the new medical lab automation partnership in Q3.
- China Exposure: Monitor the trend of revenue decline in Greater China and the sustainability of the shift to European and Other Asian markets.
- Automotive Sector: Assess the duration of the weakness in the automotive industry and its potential impact on future gross margins.
- Cash Flow Sustainability: Review the ability to maintain high operating cash flow ($83.1M YTD) while funding significant share repurchases and dividends.